Antitumor agent. It is effective in chronic myeloid leukemia, acute lymphoblastic leukemia, inoperable and / or metastatic malignant tumor stromal gastrointestinal tract, systemic mastocytosis, dermatofibrosarcoma , HES / CEL, MDS / MPD.
Treatment of influenza in adults and children over the age of 12 years.
Prevention of influenza in adults and adolescents over 12 years of age who are at high risk of infection with the virus (in military units and large production teams, in weakened patients).
Pharmacological effect- vasodilator, improving brain blood circulation, improving peripheral circulation. Cinnarizine intake is shown in the following diseases: vestibular disorders (including Meniere's disease, vertigo, tinnitus, nystagmus, nausea and vomiting of labyrinth origin). Prevention kinetoses ( " motion sickness" - sea and air sickness). Peripheral circulatory disorders (Charcot Syndrome, acrocyanosis, Raynaud's disease, cold extremities, diabetic angiopathy, thrombophlebitis, trophic disorders, including trophic and varicose ulcers). Chronic cerebrovascular insufficiency, including with residual problems after stroke (dizziness, tinnitus, headache, impaired memory and attention). Migraine Headache (prevention of attacks).
Pharmacotherapeutic group: peripheral vasodilator.
Pentoxifylline treatment leads to improvement of symptoms disorders of cerebral circulation. The beneficial therapeutic results were observed in the case of pentoxifylline in vascular pathology of eyes and inner ear. Improves microcirculation in the areas of impaired blood supply. At peripheral arterial occlusive disease (Charcot Syndrome) leads to longer-distance walking, elimination of night leg cramps and pain at rest. Has a beneficial effect on tissue trophic disorders (including with venous ulcers).
Pharmacotherapeutic group: angiotensin receptor antagonist II. Losartan reduces the total peripheral vascular resistance, blood pressure, has a diuretic effect. Prevents the development of myocardial hypertrophy, increases exercise tolerance in patients with chronic heart failure.
Pharmacotherapeutic group: Drugs used in the treatment of diseases of the liver and biliary tract. Formulations of bile acids.
Pharmacological effect - cholelitholytic, choleretic, hepatoprotective , cholesterol-lowering , immunomodulatory , etc.
Ademethionine is an amino acid that participates in the body in various metabolic processes.
Indications for use
The drug is indicated for the treatment of adults with:
- intrahepatic cholestasis with precirrotic and cirrhotic conditions,
Intrahepatic cholestasis during pregnancy;
- symptoms of depression.
Pramipexole is a dopamine receptor agonist, with high selectivity and specificity, it binds to the dopamine receptors of subgroup D2, of which it has the most pronounced affinity for D3 receptors.
Treatment of signs and symptoms of idiopathic Parkinson's disease in adults (as a monotherapy (without levodopa) or in combination with levodopa) during the course of the disease until later stages, when the effect of levodopa decreases or becomes unstable and the therapeutic effect ("on-off" phenomenon).
Symptomatic treatment of idiopathic restless leg syndrome from moderate to severe in adults in doses of not more than 0.75 mg.